Cbdmd Inc Stock Performance
| YCBD Stock | USD 0.27 0.06 18.18% |
The firm shows a Beta (market volatility) of 0.19, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CbdMD's returns are expected to increase less than the market. However, during the bear market, the loss of holding CbdMD is expected to be smaller as well. At this point, cbdMD Inc has a negative expected return of -0.41%. Please make sure to confirm CbdMD's treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if cbdMD Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days cbdMD Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
| Begin Period Cash Flow | 1.8 M |
CbdMD |
CbdMD Relative Risk vs. Return Landscape
If you would invest 44.00 in cbdMD Inc on December 17, 2024 and sell it today you would lose (17.00) from holding cbdMD Inc or give up 38.64% of portfolio value over 90 days. cbdMD Inc is currently does not generate positive expected returns and assumes 9.2375% risk (volatility on return distribution) over the 90 days horizon. In different words, 82% of stocks are less volatile than CbdMD, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CbdMD Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CbdMD's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as cbdMD Inc, and traders can use it to determine the average amount a CbdMD's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.044
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | YCBD |
Estimated Market Risk
| 9.24 actual daily | 82 82% of assets are less volatile |
Expected Return
| -0.41 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CbdMD is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CbdMD by adding CbdMD to a well-diversified portfolio.
CbdMD Fundamentals Growth
CbdMD Stock prices reflect investors' perceptions of the future prospects and financial health of CbdMD, and CbdMD fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CbdMD Stock performance.
| Return On Equity | -1.35 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.94) % | ||||
| Operating Margin | (0.07) % | ||||
| Current Valuation | 1.35 M | ||||
| Shares Outstanding | 4.47 M | ||||
| Price To Earning | 17.62 X | ||||
| Price To Book | 0.95 X | ||||
| Price To Sales | 0.09 X | ||||
| Revenue | 19.48 M | ||||
| EBITDA | (1.49 M) | ||||
| Cash And Equivalents | 10.55 M | ||||
| Cash Per Share | 0.17 X | ||||
| Total Debt | 1.27 M | ||||
| Debt To Equity | 0.11 % | ||||
| Book Value Per Share | 0.80 X | ||||
| Cash Flow From Operations | (352.79 K) | ||||
| Earnings Per Share | (10.90) X | ||||
| Total Asset | 10.58 M | ||||
| Retained Earnings | (182.07 M) | ||||
About CbdMD Performance
By analyzing CbdMD's fundamental ratios, stakeholders can gain valuable insights into CbdMD's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CbdMD has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CbdMD has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
cbdMD, Inc. produces and distributes various cannabidiol products. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina. CbdMD operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on AMEX Exchange. It employs 105 people.Things to note about cbdMD Inc performance evaluation
Checking the ongoing alerts about CbdMD for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for cbdMD Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| cbdMD Inc generated a negative expected return over the last 90 days | |
| cbdMD Inc has high historical volatility and very poor performance | |
| cbdMD Inc has some characteristics of a very speculative penny stock | |
| cbdMD Inc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 19.48 M. Net Loss for the year was (3.7 M) with profit before overhead, payroll, taxes, and interest of 22.34 M. | |
| cbdMD Inc currently holds about 10.55 M in cash with (352.79 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17. | |
| cbdMD Inc has a frail financial position based on the latest SEC disclosures | |
| Roughly 16.0% of the company outstanding shares are owned by insiders |
- Analyzing CbdMD's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CbdMD's stock is overvalued or undervalued compared to its peers.
- Examining CbdMD's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CbdMD's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CbdMD's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CbdMD's stock. These opinions can provide insight into CbdMD's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CbdMD Stock analysis
When running CbdMD's price analysis, check to measure CbdMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CbdMD is operating at the current time. Most of CbdMD's value examination focuses on studying past and present price action to predict the probability of CbdMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CbdMD's price. Additionally, you may evaluate how the addition of CbdMD to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |